Epi-LASIK : A Confocal Microscopy Analysis of the Corneal Epithelium and Anterior Stroma.

Sponsor
Asociación para Evitar la Ceguera en México (Other)
Overall Status
Completed
CT.gov ID
NCT00599690
Collaborator
(none)
10
1
1
20
0.5

Study Details

Study Description

Brief Summary

To evaluate the confocal microscopy findings at the corneal epithelium and anterior stroma after epi-LASIK Surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Epi-LASK
N/A

Detailed Description

10 eyes of 10 patients underwent epi-LASK, epithelial flaps were created with the Amadeus II, epi-LASIK-LASIK microkeratome (Ziemer ophthalmics systems AG, Switzerland). A Visx star 4 system (Visx, Santa Ana, CA, USA) was used to perform the laser ablation in all eyes. A central scan of the total corneal thickness was taken with the confocal microscope (Confoscan 4, Fortune Technologies, Italy) before and at 2 weeks and 1 month after surgery. Corneal epithelial thickness and the Anterior stroma morphology were analyzed by using the NAVIS software V. 3.5.0 (NIDEK, Multi-Instrument Diagnostic System, Japan).

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Epi-LASIK : A Confocal Microscopy Analysis of the Corneal Epithelium and Anterior Stroma.
Study Start Date :
Jan 1, 2006
Actual Primary Completion Date :
Jan 1, 2006
Actual Study Completion Date :
Sep 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: A

Epithelial flaps were created with the Amadeus II, epi-LASIK-LASIK microkeratome (Ziemer ophthalmics systems AG, Switzerland). A Visx star 4 system (Visx, Santa Ana, CA, USA) was used to perform the laser ablation in all eyes

Procedure: Epi-LASK
10 eyes of 10 patients underwent epi-LASK, epithelial flaps were created with the Amadeus II, epi-LASIK-LASIK microkeratome (Ziemer ophthalmics systems AG, Switzerland). A Visx star 4 system (Visx, Santa Ana, CA, USA) was used to perform the laser ablation in all eyes

Outcome Measures

Primary Outcome Measures

  1. A central scan of the total corneal thickness was taken with the confocal microscope (Confoscan 4, Fortune Technologies, Italy) [Before and at 2 weeks and 1 month after surgery]

Secondary Outcome Measures

  1. There are no secondary outcome measures specified for this study [There are no secondary outcome measures specified for this study]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients asking for epi-LASIK surgery

  • Patients with stable refraction in the last year

  • Patients without systemic and ocular disease

  • Patients with 500 microns in pachymetry

  • Normal topography

Exclusion Criteria:
  • Patients cannot attend their appointments

  • Residual, recurrent or active ocular disease

  • Previous ocular surgery except LASIK

  • Autoimmune or connective tissue disease

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Asociación Para Evitar la Ceguera en Mëxico, Hospital "Luis Sánchez Bulnes". Mexico city Distrito Federal Mexico 04030

Sponsors and Collaborators

  • Asociación para Evitar la Ceguera en México

Investigators

  • Principal Investigator: Ramirez F Manuel, MD, Asociación para Evitar la Ceguera en México

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00599690
Other Study ID Numbers:
  • Cornea 3
First Posted:
Jan 24, 2008
Last Update Posted:
Jan 29, 2008
Last Verified:
Nov 1, 2007

Study Results

No Results Posted as of Jan 29, 2008